A New Paradigm for HIV Treatment: Targeted Degradation of HIV Reverse Transcriptase via the Ubiquitin-Proteasome PathwayREYNOLDS, ROBERT CNational Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1R21AI157362-01), $205,425USD, 2020-11-06 -- 2022-08-31